RHOJ and neoplasm: By contrast, the size of Rhoj-KO EPCAM− tumours was stable during the 3 weeks of cisplatin/5FU treatment, showing the short-term and long-term sensitization to chemotherapy after Rhoj deletion (Fig. 2k).